Our Services
Medical Information
Helpful Resources
Published on: 8/20/2026
What is the best ARB for high blood pressure? Comparing and differentiating ARB medications for hypertension.
Angiotensin receptor blockers (ARBs) are a widely prescribed class of medications used to treat high blood pressure (hypertension), heart failure, and other cardiovascular conditions. ARBs work by blocking the action of angiotensin II, a hormone that narrows blood vessels and raises blood pressure. Common ARBs include losartan, valsartan, olmesartan, irbesartan, and telmisartan.
While all ARBs share the same basic mechanism, they differ in key ways:
- Efficacy: Some ARBs, like telmisartan, offer longer-lasting blood pressure control due to a longer half-life.
- Safety profile: Side effects such as dizziness, elevated potassium, or kidney function changes may vary between drugs.
- Specific indications: Certain ARBs are FDA-approved for additional uses, such as diabetic nephropathy (losartan, irbesartan) or heart failure (valsartan, candesartan).
Choosing the right ARB depends on your individual health profile, other medical conditions, and how your body responds to treatment.
If you're experiencing symptoms like high blood pressure, chest discomfort, shortness of breath, or swelling, understanding the potential cause is the critical first step. Rather than guessing, take a free, instant, online symptom check to get personalized insights based on your symptoms and help you decide what to do next—whether that's a lifestyle change, a doctor's visit, or a medication review.
Reviewed for medical accuracy: 07/15/2026
Quick answers
Frequently Asked Questions
4 answersThe most common questions people search after this page
Concerned about your symptoms?
Explanation
Losartan
- Efficacy: Losartan is one of the most studied ARBs and is effective in lowering blood pressure. It has also been shown to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.
- Additional Benefits: It may have protective effects on the kidneys, making it a good choice for patients with diabetes.
Valsartan
- Efficacy: Valsartan is effective in reducing blood pressure and is often used in patients with heart failure and post-myocardial infarction (heart attack).
- Additional Benefits: It has been shown to improve outcomes in heart failure patients and is often preferred in this population.
Irbesartan
- Efficacy: Irbesartan is effective in lowering blood pressure and is particularly noted for its renal protective effects in patients with diabetic nephropathy.
- Additional Benefits: It may be a good option for patients with both hypertension and chronic kidney disease.
Candesartan
- Efficacy: Candesartan is effective in managing hypertension and is also used in heart failure management.
- Additional Benefits: It has a longer half-life, which may allow for once-daily dosing, improving patient adherence.
Telmisartan
- Efficacy: Telmisartan is effective in lowering blood pressure and has a longer duration of action, which can be beneficial for once-daily dosing.
- Additional Benefits: It has been shown to improve insulin sensitivity and may be beneficial for patients with metabolic syndrome.
Comparative Efficacy and Safety
- Efficacy: Studies have shown that while all ARBs are effective in lowering blood pressure, individual responses may vary. Some patients may respond better to one ARB over another due to genetic factors or specific health conditions. If you're experiencing symptoms and want to understand what might be affecting your health, try our free AI symptom checker for personalized insights.
- Safety: Generally, ARBs are well-tolerated, with a lower incidence of cough compared to ACE inhibitors. However, side effects can include dizziness, hyperkalemia (high potassium levels), and renal impairment. The choice of ARB may depend on the patient's overall health, comorbidities, and potential drug interactions.
(References)
Dézsi CA. The Different Therapeutic Choices with ARBs. Which One to Give? When? Why? Am J Cardiovasc Drugs. 2016 Aug;16(4):255-266. doi: 10.1007/s40256-016-0165-4. PMID: 26940560; PMCID: PMC4947116.
Abraham HM, White CM, White WB. The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases. Drug Saf. 2015 Jan;38(1):33-54. doi: 10.1007/s40264-014-0239-7. PMID: 25416320; PMCID: PMC4303500.
Tell your friends about us.
We would love to help them too.
For First Time Users
What is Ubie’s Doctor’s Note?
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.